Lyra Therapeutics's total assets for Q2 2025 were $52.57M, a decrease of -6.65% from the previous quarter. LYRA total liabilities were $50.95M for the fiscal quarter, a -2.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.